Mallikarjun Reddy Sura

Title: Mallikarjun Reddy Sura: Innovator in Pharmaceutical Chemistry

Introduction

Mallikarjun Reddy Sura is a notable inventor based in Kadapa, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzyme activities. His work is characterized by a focus on innovative solutions for medical challenges.

Latest Patents

Mallikarjun Reddy Sura holds a patent for "Heterocyclic PAD4 inhibitors." This patent involves substituted heterocyclic compounds of Formula (Ia), which serve as inhibitors of the PAD4 enzyme. The disclosure outlines methods for preparing these compounds, pharmaceutical compositions that include them, and their applications in treating diseases associated with PAD4 enzyme activity. He has 1 patent to his name.

Career Highlights

Mallikarjun is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work at this prestigious company allows him to collaborate with other experts in the field and contribute to groundbreaking pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Kumaravel Selvakumar and Venkatram Reddy Paidi. Their collaboration fosters a dynamic environment for innovation and research.

Conclusion

Mallikarjun Reddy Sura exemplifies the spirit of innovation in pharmaceutical chemistry through his patent and ongoing work at Bristol-Myers Squibb Company. His contributions are paving the way for new treatments and advancements in medical science.